Background: The use of nanobiomaterials is increasing each day. Among the immense variety of
nanomaterials developed and studied the hydroxyapatite is one of the most ones.
Objective: In this study we developed and tested nano-hydroxyapatite dopped with Ho-166 for bone cancer.
Results: The results showed that the nano-hydroxyapatite dopped with Ho-166 has a great affinity for the bone.
Conclusion: The pre-clinical studies support the use as a nano-radiopharmaceuticals for bone cancer treatment and
Keywords: Radiopharmaceuticals, nanotechnology, oncology, scanning electron microscopy, transmission electron microscopy.
Rights & PermissionsPrintExport